[1]白鹏飞,张艳君,李 敏.荆芥连翘汤加减从肺论治溃疡性结肠炎疗效及对患者肠黏膜屏障功能、免疫调节、氧化应激指标的影响*[J].陕西中医,2020,(7):897-900.[doi:DOI:10.3969/j.issn.10007369.2020.07.017]
　BAI Pengfei,ZHANG Yanjun,LI Min..Effect of treating ulcerative colitis with nepeta forsythia decoction and its influence on intestinal barrier function,immune regulation and oxidative stress[J].,2020,(7):897-900.[doi:DOI:10.3969/j.issn.10007369.2020.07.017]
点击复制

荆芥连翘汤加减从肺论治溃疡性结肠炎疗效及对患者肠黏膜屏障功能、免疫调节、氧化应激指标的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年7期
页码:
897-900
栏目:
临床研究
出版日期:
2020-07-05

文章信息/Info

Title:
Effect of treating ulcerative colitis with nepeta forsythia decoction and its influence on intestinal barrier function,immune regulation and oxidative stress
作者:
白鹏飞; 张艳君; 李 敏
河北省唐山市中医医院脾胃科(唐山 063000)
Author(s):
BAI Pengfei; ZHANG Yanjun; LI Min.
Department of Spleen and Stomach,Tangshan Traditional Chinese Medicine Hospital in Hebei Province(Tangshan 063000)
关键词:
溃疡性结肠炎;  荆芥连翘汤;  从肺论治;  肠膜屏障功能;  免疫调节;  氧化应激指标
Keywords:
Ulcerative colitis;  Nepeta forsythia soup;  Treatment from lung;  Intestinal mucosal barrier function;  Immune regulation;  Oxidative stress index
分类号:
R516.1
DOI:
DOI:10.3969/j.issn.10007369.2020.07.017
文献标志码:
A
摘要:
目的:观察荆芥连翘汤加减从肺论治溃疡性结肠炎的效果,分析其对肠黏膜屏障功能、免疫调节、氧化应激指标的影响。方法:将80例溃疡性结肠炎患者按照随机数字表法分为对照组和观察组,每组各40例,对照组患者予以美沙拉嗪肠溶片,观察组患者则在此基础上加用荆芥连翘汤加减内服治之,两周为1个疗程,连续治疗4个疗程。测定肠黏膜屏障功能、免疫调节、氧化应激指标变化,评价用药的有效性和安全性。结果:观察组有效率90.00%(36/40),与对照组的有效率70.00%(29/40)的相比明显升高(χ2=5.000,P<0.05); 治疗后,两组患者的肠黏膜屏障功能均有所改善,D-乳酸、内毒素、DAO水平显著低于治疗前(P<0.05),以观察组明显低于对照组(P<0.05); 观察组患者治疗后患者治疗后TNF-α、IL-8、β-EP含量显著低于对照组,IL-2含量显著高于对照组(P<0.05); 治疗后,观察组治疗后的SOD水平显著高于对照组,MAD 、LPO水平显著低于对照组(P<0.05); 治疗过程中,观察组与对照组患者的不良反应发生率分别为5.00%、15.00%,但差异无统计学意义(χ2=2.222,P>0.05)。结论:荆芥连翘汤加减内服从肺论治溃疡性结肠炎的效果满意,利于保护肠黏膜屏障,初步分析可能与纠正机体的免疫状态及降低肠黏膜氧化应激水平有关。
Abstract:
Objective:To observe the effect of nepeta forsythia decoction on ulcerative colitis,and to analyze its effect on intestinal mucosal barrier function,immune regulation and oxidative stress.Methods:80 patients with ulcerative colitis were divided into the control group and the observation group with 40 cases each according to the random number table method.Patients in the control group were given mesalazine enteric-dissolution tablets,while patients in the observation group were treated with nepeta forsythia decoction plus internal administration.The changes of intestinal mucosal barrier function,immune regulation and oxidative stress were measured,and the efficacy and safety of the drug were evaluated.Results:The effective rate in the observation group was 90.00%(36/40),which was significantly higher than that in the control group of 70.00%(29/40)(χ2=5.000,P<0.05).After treatment,the intestinal mucosal barrier function of patients in both groups was improved,and the levels of d-lactic acid,endotoxin and DAO were significantly lower than before treatment(P<0.05),so that the observation group was significantly lower than the control group(P<0.05).After treatment,the contents of TNF-,IL-8 and β-EP in the observation group were significantly lower than those in the control group,and the contents of IL-2 were significantly higher than those in the control group(P<0.05).After treatment,SOD level in the observation group was significantly higher than that in the control group,and MAD and LPO levels were significantly lower than those in the control group(P<0.05).During the treatment,the incidence of adverse reactions was 5.00% in the observation group and 15.00% in the control group,but the difference was not statistically significant(χ2=2.222,P>0.05).Conclusion:The effect of nepeta forsythia decoction on ulcerative colitis is satisfactory,which is conducive to protecting the intestinal mucosal barrier.Preliminary analysis of the mechanism of its effect may be related to correcting the immune state of the body and reducing the level of intestinal mucosal oxidative stress.

参考文献/References:

[1] Dong C,Metzger M,Holsbo E,et al.Systematic review with meta-analysis:mortality in acute severe ulcerative colitis [J].Aliment Pharmacol Ther,2020,51(1):8-33.
[2] Le Berre C,Ananthakrishnan AN,Danese S,et al.Ulcerative colitis and crohn's disease have similar burden and goals for treatment[J].Clin Gastroenterol Hepatol,2020,18(1):14-23.
[3] 沈春艳,朱叶珊.中医药对溃疡性结肠炎患者黏膜屏障影响的研究进展[J].湖南中医杂志,2019,35(9):163-165.
[4] 中华中医药学会脾胃病分会.溃疡性结肠炎中医诊疗共识意见[J].中华中医药杂志,2010,25(6):891-894.
[5] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2012年广州)[J].中华内镜杂志,2012,51(10):818-831.
[6] 乔 峰,强文娟,高 东,等.葛根芩连汤配合针刺治疗溃疡性结肠炎活动期大肠湿热证临床研究[J].陕西中医,2019,40(11):1516-1519.
[7] 缪志伟,叶 柏.从瘀毒论治溃疡性结肠炎临证心得[J].江苏中医药,2019,51(11):44-46.
[8] 张艳君,常玉洁.荆芥连翘汤加减治疗溃疡性结肠炎32例疗效观察[J].中医药导报,2016,22(21):64-66.
[9] 陈伦虎,宋方敏,李和平,等.高迁移率族蛋白B1在溃疡性结肠炎组织中的表达及其与氧化应激、屏障功能损伤的相关性研究[J].现代消化及介入诊疗,2019,24(10):1104-1108.
[10] 鲁 霞,罗 黎.炎症性肠病患者Th22细胞亚群和IL-22水平变化及其临床意义[J].中国微生态学杂志,2019,31(10):1203-1206.
[11] 殷 娟,唐西怀,贾晶晶.溃疡性结肠炎患者的肠道菌群分布与血清TNF-α、IL-6水平的相关性[J].检验医学与临床,2019,16(23):3421-3423.
[12] 李博林,赵丹阳,杜朋丽,等.化浊解毒方对溃疡性结肠炎大鼠血清IL-1β、IL-8含量及结肠黏膜NF-κB mRNA表达的影响[J].广州中医药大学学报,2019,36(7):1045-1049.
[13] 翟月华,高明焕.自拟清肠愈疡汤经验方口服、中药灌肠对重度溃疡性结肠炎患者肠道菌群、免疫功能、血清HIF-1α、TGF-β1、β-EP水平的影响[J].环球中医药,2018,11(6):941-944.
[14] 殷银霞,刘永华,刘香玉,等.久泻灵颗粒对脾肾阳虚型溃疡性结肠炎大鼠IL-2、IL-4、IL-10表达的影响[J].中国老年学杂志,2017,37(23):5766-5768.
[15] 陈风慧,王晓华,范春梅.补充外源性维生素D对老年溃疡性结肠炎患者氧化-抗氧化失衡、肠道黏膜屏障和临床预后的影响[J].陕西医学杂志,2018,47(12):1634-1637.
[16] 张渊博,王晓峰,王 锐,等.荆芥防风对溃疡性结肠炎治疗效果的影响[J].山东中医杂志,2018,37(7):557-559.
[17] 周荣荣,张 萌,朱 彦,等.含党参方剂的数据挖掘及防治胃肠道疾病的分子机制[J].药学学报,2018,53(9):1422-1428.
[18] 鲍炳州,朱 超,吴生兵,等.基于16S rDNA测序技术探索白头翁汤灌肠对湿热型溃疡性结肠炎大鼠肠道菌群的影响[J].安徽中医药大学学报,2019,38(6):62-68.

相似文献/References:

[1]陈 岚,贾 波△,邓怀涵,等.基于“逆流挽舟”法探索人参败毒散对溃疡性结肠炎模型大鼠〖JZ〗胃肠功能的影响及作用机制*[J].陕西中医,2019,(3):283.
[2]陈立冬,刘智慧,于 蕊.康复新液灌肠联合美沙拉嗪治疗溃疡性结肠炎疗效研究*[J].陕西中医,2019,(9):1187.
[3]乔峰,强文娟,高东,等.葛根芩连汤配合针刺治疗溃疡性结肠炎活动期大肠湿热证临床研究*[J].陕西中医,2019,(11):1516.
　QIAO Feng,QIANG Wenjuan,GAO Dong,et al.Gegen Qinlian decoction combined with acupuncture for ulcerative colitis with large intestine dampheat syndrome at active stage[J].,2019,(7):1516.
[4]史英,张铁△,祝斌野,等.溃结2号方治疗脾虚湿盛型溃疡性结肠炎临床研究*[J].陕西中医,2019,(11):1520.
　SHI Ying,ZHANG Tie,ZHU Binye,et al.Clinical observation on Kuijie No.2 recipe in treating ulcerative colitis of spleen deficiency and dampness[J].,2019,(7):1520.
[5]赵克学,徐 辰,戴高中,等.愈疡膏外敷联合西药治疗复发型活动期溃疡性结肠炎临床研究*[J].陕西中医,2020,(5):600.[doi:DOI:10.3969/j.issn.10007369.2020.05.013]
　ZHAO Kexue,XU Chen,DAI Gaozhong,et al.Observation on the efficacy of Yuyang plaster combined with western medicine in the treatment of recurrent active ulcerative colitis[J].,2020,(7):600.[doi:DOI:10.3969/j.issn.10007369.2020.05.013]
[6]郭 琳,王雅婷,考延磊,等.闫雪洁运用寒热并用法治疗溃疡性结肠炎经验*[J].陕西中医,2020,(8):1148.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.036]
　GUO Lin,WANG Yating,KAO Yanlei,et al.Clinical experience of YAN Xuejie in treating ulcerative colitis with the theory of combination of cold and heat[J].,2020,(7):1148.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.036]
[7]梁 想,王梅青△.参苓白术散联合美沙拉嗪治疗溃疡性结肠炎疗效研究[J].陕西中医,2020,(9):1251.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.021]
[8]袁子云,杜晓泉△.杜晓泉运用健脾调肠汤治疗溃疡性结肠炎脾虚湿热证经验总结*[J].陕西中医,2020,(12):1800.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.032]
[9]邹林焘,邹正华,杜学芳.清肠解毒汤治疗溃疡性结肠炎湿热内蕴证临床研究[J].陕西中医,2021,(5):597.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.013]
　ZOU Lintao,ZOU Zhenghua,DU Xuefang.Qingchang Jiedu decoction in the treatment of ulcerative colitis with internal accumulation of damp-heat[J].,2021,(7):597.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.013]
[10]张 波,惠永峰,李海玲,等.益脾祛湿理肠汤治疗溃疡性结肠炎疗效及对患者肠黏膜屏障功能的影响[J].陕西中医,2021,(8):1024.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.009]
　ZHANG Bo,HUI Yongfeng,LI Hailing,et al.Yipi Qushi Lichang decoction on ulcerative colitis and its influence on intestinal mucosal barrier function[J].,2021,(7):1024.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.009]

备注/Memo

备注/Memo:
*河北省中医药管理局科研课题(2014262)
更新日期/Last Update: 2020-07-09